Eton Pharmaceuticals, Inc. — Form D
Eton Pharmaceuticals, Inc. of DEER PARK, IL, a company, filed a Form D exempt-offering notice with the SEC on 2020-04-08. The offering totals $7.5M, of which $7.5M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2020-04-08
- Form: D
- Accession: 0001493152-20-006039
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $7.5M
- Amount sold: $7.5M
- Investors: 2
- Date of first sale: 2020-03-26
- Security types: equity
- Revenue range: $1 - $1,000,000
- SEC file number: 021-364522
Issuer
- Name: Eton Pharmaceuticals, Inc.
- CIK: 0001710340
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2017
- Address: 21925 W. FIELD PKWY, DEER PARK, IL, 60010
- Phone: 847-616-5734
Officers, directors & promoters (10)
| Name | Role | Location |
|---|
| Mark L Baum | Director | Nashville, TN |
| Sean Brynjelsen | Director | Deer Park, IL |
| Charles J Casamento | Director | Deer Park, IL |
| Paul V Maier | Director | Deer Park, IL |
| Norbert G Riedel | Director | Deer Park, IL |
| Sean Brynjelsen | Executive Officer | Deer Park, IL |
| William Wilson Troutman | Executive Officer | Deer Park, IL |
| Charles Casamento | Director | SAN FRANCISCO, CA |
| Mark Baum | Director | San Diego, CA |
| Andrew Boll | Director | San Diego, CA |
Other filings by this issuer (1)
More